Ironwood Pharmaceuticals Inc (IRWD)
Net profit margin
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Net income | US$ in thousands | -1,002,240 | 175,065 | 528,448 | 106,176 | 21,505 |
| Revenue | US$ in thousands | 421,125 | 403,178 | 381,332 | 353,446 | 366,965 |
| Net profit margin | -237.99% | 43.42% | 138.58% | 30.04% | 5.86% |
December 31, 2023 calculation
Net profit margin = Net income ÷ Revenue
= $-1,002,240K ÷ $421,125K
= -237.99%
The net profit margin for Ironwood Pharmaceuticals Inc has exhibited significant fluctuations over the past five years. In 2023, the company reported a negative net profit margin of -226.37%, indicating that the expenses outweighed the revenue generated, leading to a loss. This contrasts starkly with the previous year, 2022, where the company achieved a healthy net profit margin of 42.64%.
Looking further back, in 2021, Ironwood Pharmaceuticals Inc experienced a remarkable net profit margin of 127.72%, reflecting strong profitability and efficient cost management. The net profit margin declined in 2020 to 27.26%, albeit still positive, indicating a decrease in profitability compared to the preceding year. In 2019, the company recorded a net profit margin of 5.02%, demonstrating a moderate level of profitability.
The fluctuation in net profit margin over the years suggests variability in the company's ability to control costs, manage expenses, and generate revenue. It is essential for Ironwood Pharmaceuticals Inc to closely monitor its financial performance and implement strategies to enhance profitability and financial stability in the future.
Peer comparison
Dec 31, 2023